This is a rare genetic condition where the body's immune system doesn't work properly. It affects a type of white blood cell called a phagocyte. These cells normally fight off infections, but in this disease, they get stuck on bacteria and can't get rid of them. This leads to recurring infections and the formation of small lumps called granulomas in different parts of the body. It can be inherited in two ways: one type is passed down through the X chromosome, and the other type is inherited from both parents.
Every report comes from a Lived member, sent anonymously.
Have you tried Bactrim (Trimethoprim-Sulfamethoxazole) for Chronic Granulomatous Disease?
Chronic granulomatous disease (CGD) is a rare inherited immune disorder in which certain white blood cells cannot kill some types of bacteria and fungi. These cells, called phagocytes, normally swallow germs and destroy them with a burst of toxic oxygen molecules. In CGD that burst is missing or weak, so the cells take germs in but cannot finish them off. The result is two kinds of problems. The first is serious, repeated infections, most often pneumonia, abscesses (pockets of pus) in the lungs, liver, skin or lymph nodes, and bone infections. Mold infections, especially from Aspergillus, are among the most dangerous. The second is excess inflammation. The immune system walls off germs and irritants in small clusters of cells called granulomas, which give the disease its name and can block or damage organs such as the bowel, the stomach outlet and the bladder. Symptoms usually start in childhood, but some people, particularly those with milder forms, are not diagnosed until adulthood.
CGD is caused by changes in genes that build an enzyme complex called NADPH oxidase, which produces the oxygen burst phagocytes use to kill germs. Six genes are known. The most common form involves the CYBB gene on the X chromosome. Because males have only one X chromosome, this X-linked form affects mostly boys and men, and it is usually passed on through mothers who carry the gene change. The other forms are autosomal recessive: a person is affected only after inheriting a changed copy from each parent, so males and females are affected equally. Some gene changes leave a little oxidase activity working. People with more remaining activity, including many with the NCF1 form, tend to have a milder course than people with none. Women who carry the X-linked gene change are not always unaffected. Depending on how many of their cells rely on the working copy, carriers can have mouth ulcers, lupus-like rashes and bowel inflammation, and those with fewer than about 20 percent normally working neutrophils can get CGD-type infections. That share can shift over time. Nothing a person does causes CGD. The infections themselves come from germs that are common in the environment, particularly mold spores in decaying plant matter, so certain exposures raise the chance of a serious infection.
CGD is usually suspected after unusual or repeated deep infections, such as a liver abscess, a lung infection caused by Aspergillus mold, or infection with germs like Serratia, Burkholderia or Nocardia that rarely trouble healthy people. Bowel inflammation that looks like Crohn's disease, or a blockage at the stomach outlet in an infant, can also be the first sign. Sometimes testing follows a relative's diagnosis. The standard test is the dihydrorhodamine (DHR) test, a blood test that stimulates neutrophils (the most common phagocyte) in the lab and measures how much of the oxygen burst they produce. In CGD the burst is absent or reduced. The pattern also hints at the type: X-linked CGD usually shows almost no activity, many recessive forms show partial activity, and carriers often show two separate groups of working and non-working cells. A few other conditions, severe infection and some medicines can make the DHR result abnormal, and one mild form (NCF4) can be missed by the standard test. For these reasons genetic testing is recommended alongside it. Knowing the exact gene confirms the diagnosis, informs decisions about transplant, and allows testing and genetic counseling for relatives.
Treatment aims to prevent infections, treat them quickly when they happen and control inflammation. For many people, a stem cell transplant can cure the disease. For people who have not had a transplant, prevention is lifelong. A daily antibiotic, usually trimethoprim-sulfamethoxazole, has greatly reduced bacterial infections. A daily antifungal, usually itraconazole, guards against mold. Doctors often check itraconazole blood levels because absorption varies, and it interacts with many other medicines. Some people also take interferon gamma-1b (Actimmune), an injected immune-signaling protein given three times a week that is FDA-approved to reduce serious infections in CGD. Its benefit was shown before antifungal prevention became routine, so how much it adds today is uncertain, and it often causes flu-like fever, aches and tiredness. Specialists decide on it case by case, and it never replaces the daily antibiotic and antifungal. When an infection does occur, finding the exact germ matters, often through imaging, cultures and sometimes a biopsy or drainage, because it guides which antibiotic or antifungal will work. Granulomas and CGD-related bowel inflammation usually respond to corticosteroids (steroids), and mesalamine or other immune-calming medicines may be used for the bowel. Relapses are common. These treatments need care because suppressing the immune system raises infection risk; TNF-blocking drugs, often used for Crohn's disease, are generally avoided in CGD for this reason. A hematopoietic stem cell transplant (bone marrow transplant) replaces the faulty blood-forming cells with a donor's healthy ones and can cure CGD, including its bowel inflammation. It is often recommended for X-linked CGD, for people with little or no oxidase activity, and for those with severe infections or hard-to-control inflammation. With a fully matched related or unrelated donor, survival now exceeds 90 percent in recent reports, and results are better when transplant happens younger and before many complications. It still carries serious risks, so the decision weighs the course of the person's disease against them. Gene therapy, which corrects a person's own stem cells, is promising but remains experimental and is available only through research studies.
CGD is lifelong unless a transplant succeeds, and its course varies widely, even within one family. With daily prevention, many people go long stretches without a serious infection, but infections and inflammatory flares remain the main threats. With treatment, most people now live into mid- to late adulthood, and transplant has changed the outlook for many. Daily life involves some deliberate habits. Mold spores in decaying plants are a major danger, so people with CGD should avoid compost, mulch, hay, raking leaves and dusty places like construction sites. Swimming in lakes, rivers or brackish water is also discouraged, while well-chlorinated pools are considered safe. Travel to areas with tuberculosis or unsafe drinking water calls for planning with the care team. Most routine vaccines are safe and recommended, including live viral vaccines such as measles-mumps-rubella and chickenpox. Live bacterial vaccines, namely BCG (a tuberculosis vaccine given at birth in many countries) and the oral typhoid vaccine, should be avoided. Regular visits with an immunologist include blood tests for inflammation, liver health and drug levels, along with periodic lung imaging or breathing tests. Bowel, liver and lung inflammation can develop gradually, so new symptoms are worth raising between visits. Living with a chronic immune disorder, or caring for a child who has one, can be tiring and stressful. Specialists commonly recommend mental health support, and patient organizations such as the Immune Deficiency Foundation connect families with others facing the same disease.
Ask a doctor about testing for CGD when someone has repeated or unusually deep infections, such as abscesses in the liver or lungs, mold pneumonia or bone infections, or when a close relative has CGD. Female relatives of someone with X-linked CGD who have recurrent infections, mouth ulcers, rashes or bowel symptoms should ask about carrier testing. For someone already diagnosed, serious infections can look mild until they are advanced, so contact the care team promptly about a temperature of 101°F (38.3°C) or higher lasting more than an hour or measured more than once in a day, a low-grade fever that lingers, a new cough, belly pain, swollen lymph nodes, a skin sore or swelling, or bone or muscle tenderness. Ongoing diarrhea, blood in the stool, weight loss or vomiting after meals should also be reported, since they can signal bowel inflammation or a narrowed stomach outlet. The team decides whether an office visit or emergency care is needed based on the person's history. Fever with shortness of breath after exposure to mulch, hay or dead leaves, and any change in vision, need urgent medical assessment the same day.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Chronic Granulomatous Disease is like, what's helped you, or ask the community a question.